Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›NOI - LC MS Analysis Processed Mouse Serum Samples

U.S. Department Of Health And Human Services·Maryland

NOI - LC MS Analysis Processed Mouse Serum Samples

Closes 6/8/2026$56kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking a contractor to perform LC-MS analysis of 280 processed mouse serum samples using the Seer Proteograph Platform and Proteograph Analysis Suite (PAS). The contractor will be required to provide high-quality LC-MS–based proteomic profiling of the samples to support ongoing aging research. The contract will have a period of performance of 12 months, from 06/08/2026 to 06/07/2027. The contractor will be required to perform HPLC mass spectrometry analysis with a data-independent acquisition (DIA) mode on the samples and provide electronic copies of spreadsheet or database files including quantitative measurement of all proteins assayed in the provided serum samples. Some key points to consider: • The contractor must have experience in high-throughput lab methods and be able to perform unbiased, large-scale, comprehensive HPLC mass spectrometry analysis. • The contractor must be able to provide high-quality LC-MS–based proteomic profiling of the samples. • The contract will have a fixed price of $56,000.00. • The contractor will be required to provide progress reports during the contract period.

Attached files

Contact

Nicholas Capobianco(Contracting Officer)

[email protected]

(000) 000-0000

Key dates

Opened
5/28/2026
Closes
6/8/2026
Duration
365 days

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
541380
Solicitation №
75N98026Q00465

Budget estimate

$56,000

The estimated budget for this contract is $56,000.00, as stated in the solicitation document. This amount is likely based on the cost of performing the required LC-MS analysis and providing the necessary personnel and equipment. The budget may be influenced by factors such as the complexity of the analysis, the number of samples to be analyzed, and the level of expertise required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

Top match · 66%

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. Department Of Health And Human Services·Indiana

64% match

NOI - B2B Award entitled - Developing Red Cell-Sp

Closes 11/4/2026Opened 10/20/2026

U.S. Department Of Health And Human Services·Maryland

64% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. Department Of Health And Human Services·Maryland

64% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

Iowa State University·Iowa

63% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

63% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. Department Of Health And Human Services·Maryland

62% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

61% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

University of Massachusetts·Massachusetts

61% match

UMass Amherst University Health Services - Laboratory and/or Clinical Molecular Analyzer

Closes 11/6/2026Opened 10/5/2026

U.S. Department Of Health And Human Services·Maryland

61% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

Colorado Department of Public Health and Environment·Colorado

61% match

NBS Laboratory Information Management System - OIT

Closes 11/2/2026Opened 9/30/2026

U.S. National Institutes of Health·United States of America

61% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. Department Of Veterans Affairs·Texas

60% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

60% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

60% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. Department Of Agriculture·Georgia

60% match

STEC Media

Closes 12/8/2026Opened 10/28/2026

Colorado Department of Public Health and Environment – Laboratory Services Division – Newborn Screening Program·Colorado

60% match

NBS Laboratory Information Management System - OIT

Closes 11/2/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

60% match

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/17/2021

U.S. National Institutes of Health·United States of America

60% match

Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)

Closes 3/5/2027Opened 9/29/2025

University of South Carolina·South Carolina

60% match

Notice Of Intent To Sole Source – University of South Carolina Collaborative ALS Research Services

Rolling / TBD closeOpened 10/5/2026

U.S. National Institutes of Health·United States of America

59% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

Nyc Department of Health and Mental Hygiene·New York

59% match

81627Y0873-Assays, reagents, and consumables for cobas® 5800, 6800v2, 8800v2, MagNa Pure96, and LightCycler systems

Closes 11/2/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

59% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. Department Of Health And Human Services·United States of America

59% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

59% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026